Asundexian lowered ischemic stroke without more major bleeding across low, intermediate, and high Framingham risk groups (all P interaction > .25).
|Articles|September 25, 2009
Alzheimer's Disease
Dr. Nina Silverberg of the National Institute on Aging, discusses Alzheimer's Disease.
Advertisement
Dr. Nina Silverberg of the National Institute on Aging, discusses Alzheimer's Disease.
Advertisement
Related to this article
Robert Mentz, MD, discusses mentorship, trial recruitment, journal growth, and surgical partnerships in heart failure care.
Advertisement
Advertisement
Trending on HCPLive
1
Cannabis Use Tied to Higher Odds of Stroke, Cardiovascular Disease
2
STREAM: Statin Discontinuation Noninferior in Older Adults Without CVD
3
AHA 2026: Intensive Blood Pressure Control Reduces Events After Ischemic Stroke
4
Common Diuretic Linked to Home Blood Pressure Lowering After Stroke
5